Marinus Pharmaceuticals Inc
F:61Y
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marinus Pharmaceuticals Inc
F:61Y
|
US |
|
Oxford Square Capital Corp
NASDAQ:OXSQ
|
US |
|
E
|
Eurogroup Laminations SpA
XBER:QK9
|
IT |
|
P
|
Piotech Inc
SSE:688072
|
CN |
|
Dishman Carbogen Amcis Ltd
NSE:DCAL
|
IN |
|
S
|
Sanmina Corp
F:SAYN
|
US |
|
Vision Marine Technologies Inc
XTSX:VMAR
|
CA |
|
Suburban Propane Partners LP
NYSE:SPH
|
US |
|
D
|
Deutsche Lufthansa AG
OTC:DLAKF
|
DE |
|
Daqo New Energy Corp
NYSE:DQ
|
CN |
|
Adyen NV
F:1N8U
|
NL |
|
Lantronix Inc
NASDAQ:LTRX
|
US |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Brera Holdings PLC
NASDAQ:SLMT
|
IE |
|
P
|
PetroChina Co Ltd
SGX:K3OD
|
CN |
|
ONE Gas Inc
NYSE:OGS
|
US |
|
V
|
Vallourec SA
F:VACD
|
FR |
|
Team17 Group PLC
F:2EC
|
UK |
Bankruptcy Probability
Marinus Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Marinus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
30.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
639.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
321.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
197.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
143.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Marinus Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Marinus Pharmaceuticals Inc has total debt of 41.7m USD. This includes both short-term (0 USD) and long-term (41.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
